In this episode of The Swine Health Blackbelt Podcast, Dr. Nicholas Lauterbach from Pharmgate Animal Health explains the impact of PRRSV and why it remains one of the most costly diseases for pork producers. The discussion focuses on the efficacy of a modified live immunization strategy during a 1-4-4 L1C PRRSV challenge, using a study designed to reflect real-world production conditions. Results highlight differences in viral circulation, growth performance, and mortality under lateral challenge pressure. Listen now on all major platforms!"The lineage 1-4-4 L1C is one of, if not the most commonly found PRRSV strain today, while also causing some of the most drastic clinical signs."𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗴𝘂𝗲𝘀𝘁: Dr. Nicholas Lauterbach earned his Doctor of Veterinary Medicine from Iowa State University and has worked extensively in commercial swine systems across the Midwest. He previously served as a senior veterinarian for Smithfield Foods and currently leads technical services at Pharmgate Animal Health. His work focuses on applied swine health research, PRRSV management strategies, and field-relevant immunization strategies. Liked this one? Don’t stop now — Here’s what we think you’ll love!What you will learn:(00:00) Highlight(01:18) Introduction(01:43) Guest background(02:29) PRRSV challenge(05:41) Trial design(08:05) Results insights(10:03) Immunization outcomes(14:55) Closing thoughtsThe Swine Health Blackbelt Podcast is trusted and supported by innovative companies like:Pharmgate* Boehringer Ingelheim- Elanco𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.Website: The Swine Health Blackbelt PodcastInstagram: Swine CampusLinkedIn: Swine Campus

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related